EVELO BIOSCIENCES INC's ticker is EVLO and the CUSIP is 299734103. A total of 68 filers reported holding EVELO BIOSCIENCES INC in Q1 2022. The put-call ratio across all filers is 3.73 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $620,851 | -37.8% | 294,242 | 0.0% | 0.00% | – |
| Q1 2022 | $997,480 | -44.2% | 294,242 | 0.0% | 0.00% | – |
| Q4 2021 | $1,786,000 | -13.8% | 294,242 | 0.0% | 0.00% | – |
| Q3 2021 | $2,071,000 | -48.8% | 294,242 | 0.0% | 0.00% | -100.0% |
| Q2 2021 | $4,043,000 | +28.4% | 294,242 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $3,148,000 | – | 294,242 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 18,233,403 | $215,154,000 | 41.21% |
| HARBOURVEST PARTNERS LLC | 1,763,505 | $20,809,000 | 26.29% |
| Alphabet Inc. | 1,060,495 | $12,514,000 | 1.05% |
| SECTORAL ASSET MANAGEMENT INC | 437,500 | $5,163,000 | 0.58% |
| DC Investments Management, LLC | 36,924 | $436,000 | 0.28% |
| ARK Investment Management | 126,831 | $1,497,000 | 0.06% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 22,998 | $271,000 | 0.03% |
| Laurion Capital Management LP | 150,000 | $1,770,000 | 0.01% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 9,380 | $111,000 | 0.01% |
| CREDIT SUISSE AG/ | 440,169 | $5,194,000 | 0.01% |